4.5 Letter

Is recombinant tissue plasminogen activator treatment a safe choice in very and extremely preterm infants with intracardiac thrombosis?

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Clinical features and treatment results in preterm infants with intracardiac thrombus

Mustafa Kara et al.

Summary: In this study, medical records of premature infants diagnosed with intracardiac thrombus between January 2016 and January 2019 were retrospectively evaluated. The results showed that both low molecular weight heparin and recombinant tissue plasminogen activator had similar treatment outcomes for intracardiac thrombus in preterm infants.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2021)

Article Medicine, General & Internal

Recombinant tissue-type plasminogen activator treatment in an extremely low birth weight infant

Tomonori Kurimoto et al.

Summary: Tissue plasminogen activator can effectively treat clinical thrombosis in premature infants 11 hours after birth, showing significant therapeutic effects.

CLINICAL CASE REPORTS (2021)

Article Oncology

Thombolytic therapy in preterm infants: Fifteen-year experience

Priscila Grizante-Lopes et al.

PEDIATRIC BLOOD & CANCER (2020)

Article Obstetrics & Gynecology

Incidences, risk factors and outcomes of neonatal thromboembolism

Nongnuch Sirachainan et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2018)

Article Critical Care Medicine

Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants

Jayanti Bose et al.

PEDIATRIC CRITICAL CARE MEDICINE (2011)

Review Hematology

Neonatal and childhood right atrial thrombosis: recognition and a risk-stratified treatment approach

Janet Y. K. Yang et al.

BLOOD COAGULATION & FIBRINOLYSIS (2010)

Review Pediatrics

Thrombolysis for intravascular thrombosis in neonates and children

Leslie Raffini

CURRENT OPINION IN PEDIATRICS (2009)

Review Obstetrics & Gynecology

The evaluation and management of postnatal thromboses

M. A. Saxonhouse et al.

JOURNAL OF PERINATOLOGY (2009)

Review Hematology

Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates

Janet I. Malowany et al.

THROMBOSIS RESEARCH (2008)

Article Obstetrics & Gynecology

Successful use of tissue plasminogen activator in catheter-related intracardiac thrombus of a premature infant

MJ Torres-Valdivieso et al.

AMERICAN JOURNAL OF PERINATOLOGY (2003)

Article Pediatrics

Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature

J Hartmann et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2001)

Article Pediatrics

Early intracardiac thrombosis in preterm infants and thrombolysis with recombinant tissue type plasminogen activator

F Ferrari et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2001)